Even AML patients, in which P-glycoprotein expression affects the outcome of chemotherapy, are not routinely phenotyped, and current efforts to develop simple, intercentre reproducible protocols to detect P-glycoprotein in AML blasts have been developed (Pallis et al, 2005). This evidence concerns the gene ABCB1 and acute myeloid leukemia.